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repetitive motion disorder (ie, carpal tunnel syndrome)
that does not follow the normal healing path. The patho-
physiology is unknown, development does not appear to
depend on the magnitude of injury, and diagnosis may be
hampered by a lack of objective findings or legal issues
(accusations of malingering for the collection of disability
benefits). The hallmark of RSD is a burning extremity pain
and mobility problems out of proportion to those
expected from the injury, but other clinical manifestations
can develop, such as skin changes, vasospasm, swelling,
movement disorder, muscle atrophy, or the spreading of
RSD symptoms to the trunk or in a mirror-image pattern.
Although education is the most important method for
the treatment of RSD, the typical pain clinic treatment
protocol includes psychosocial counseling (pain coping
skills, drug abuse potential, relaxation techniques, family
support assessment), sequential drug (oral, transdermal)
trials for the optimization of pain control, physical/occu-
pational therapy, and a series of three to six local anesthetic
(bupivacaine hydrochloride) sympathetic blocks. With the
selective blocking of the sympathetic nervous system, both
the patient and the physician gain useful diagnostic infor-
mation as to whether the pain is sympathetically main-
tained and potentially responsive to sympathectomy and
Surgical sympathectomy for the treatment of disabling
posttraumatic pain syndromes was introduced more than
70 years ago.1 The entity of burning pain, sympathetic
hyperactivity, hyperesthesia, joint stiffness, muscle atrophy,
and skin changes after nerve, bone, or soft tissue injury has
been described with a variety of terms, including causalgia,
Sudeck’s atrophy, reflex sympathetic dystrophy (RSD)
syndrome, and in 1995 complex regional pain syndrome
(CRPS), by the International Association for the Study of
Pain.2,3 The best way to describe RSD is in terms of an
extremity injury caused by trauma, infection, surgery, or
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Purpose: The purpose of this study was the assessment of the efficacy of thoracoscopic cervicodorsal and open lumbar
sympathectomy for the reduction of pain severity and disability associated with reflex sympathetic dystrophy (RSD).
Methods: From 1992 to 2000, 73 patients with RSD underwent 46 video-assisted thoracoscopic (first to fourth tho-
racic ganglion) or 37 surgical lumbar (first to fourth lumbar ganglion) sympathetic chain resections. The patients were
referred from multidisciplinary pain clinics with documented sympathetically maintained pain syndrome on the basis
of reproducible more than 50% reduction in pain severity score (0, no pain; 10, most severe pain imaginable) for more
than 2 days after sympathetic block therapy. The mean duration of the RSD symptoms before sympathectomy was 26
± 14 months (range, 6 to 100 months). Postoperative pain severity score, limb disability, and overall patient satisfac-
tion were assessed by an independent third-party observer at a mean follow-up period of 30 months.
Results: No operative mortality or serious morbidity (Horner’s syndrome, bleeding that needed transfusion, wound
infection) occurred. Transient (<3-month) postprocedural sympathalgia developed in one third of the patients for cer-
vicodorsal sympathectomy and 20% of the patients for lumbar sympathectomy and was treated effectively with trigger
point/proximal ganglion block therapy or transcutaneous electrical nerve stimulation. At 3 months after sympathec-
tomy, 10% of the patients had conditions that were judged treatment failures with no reduction in pain severity or limb
disability. The remaining patients testified to more than 50% pain reduction, with pain severity scores decreasing from
a mean of 8.7 before surgery to 3.4 after sympathectomy. At 1 year, one quarter of the patients had continued signif-
icant pain relief (pain severity score, <3) and an additional 50% of the patients indicated continued but reduced pain
severity and an increase in daily/work activities. Overall, patient satisfaction (willingness to have procedure again, ben-
efit from sympathectomy) was 77% and was not significantly influenced by patient age, RSD duration/stage, or extrem-
ity involvement (lumbar, 84%; cervicodorsal, 72%).
Conclusion: Patients with RSD with a confirmed sympathetically maintained pain syndrome can realize long-term ben-
efit from surgical sympathectomy. Procedural efficacy was similar for both upper limb and lower limb RSD syndromes,
although the level of pain reduction did deteriorate with time. After sympathectomy, the patients with RSD had a low
incidence rate (7%) of “new” complex regional pain or disabling compensatory sweating syndromes. (J Vasc Surg
2002;35:269-77.)
whether sympathectomy, in some patients, may provide a
permanent cure or remission. Only patients with a signifi-
cant decrease in pain after the sympathetic block therapy
(ie, sympathetically maintained pain [SMP]) should be
considered candidates for sympathectomy.4-8 Because sur-
gical sympathectomy is an invasive procedure with poten-
tial complications, it should be reserved for patients with
SMP and a persistent RSD disability that is not responsive
to other treatment methods, including chemical sympa-
thectomy.
In the past decade, minimally invasive endoscopic
approaches to sympathetic chain excision have replaced
open surgical procedures, especially for cervicodorsal sym-
pathectomy.9,10 In this clinical review, the outcome of
video-assisted thoracoscopic sympathectomy was com-
pared with open lumbar sympathectomy for patients
referred from a multidisciplinary pain clinic with an SMP-
RSD pain syndrome. The goal of this retrospective review
was the documentation of the efficacy, the duration of
pain reduction, and the adverse sequelae of the sympa-
thectomy for upper limb and lower limb RSD syndromes,
including the development of new CRPSs during a mean
follow-up interval of 30 months.
METHODS
Patient population. From 1992 to 2000, 73 patients
who were referred from regional multidisciplinary pain
clinics with RSD for consideration of surgical (cervicodor-
sal, n = 46; lumbar, n = 37) sympathectomy were judged
to be appropriate candidates. The 56 female and 17 male
patients ranged in age from 13 to 66 years (mean, 35 ± 10
years). All the patients had clinical features of RSD
(Appendix) with positive thermographic results that indi-
cated a cold extremity and were enrolled in a pain clinic
treatment program (Fig). At the time of referral, the
patients were significantly impaired or disabled because
they were unable to perform normal daily activities or
attend school or because they had experienced loss of
employment because of pain and limb mobility problems.
Although the staging of RSD is a dying concept, in part
because of the unpredictable course of the disease, two
thirds of the patients who consented to undergo sympa-
thectomy had stage I/II symptoms and signs and one
third had stage III disease. The patient-provided pain
severity scores (0, no pain; 5, pain interferes with
daily/work activities; 10, worst pain imaginable; recorded
on a visual analogue scale) were similar in the stage I/II
(8.4 ± 1.1) and stage III (8.7 ± 1.2) patient groups. In
general, an RSD pain score in excess of 8 indicated severe,
intractable pain and limb disability, precluding employ-
ment. The clinical characteristics of the patients who
underwent either thoracoscopic dorsal or open lumbar
sympathectomy are listed in Table I. The age, gender,
duration of RSD symptoms before intervention, and clin-
ical disease stage were similar in the patients selected for
either cervicodorsal or lumbar sympathectomy. Fifteen
patients (20%) had bilateral symptoms of RSD at the time
of initial surgical sympathectomy. The duration of RSD
symptoms ranged from 6 to 100 months, with a similar
RSD onset-to-sympathectomy time interval in the cervi-
codorsal (25 ± 20 months) and lumbar (26 ± 15 months)
sympathectomy groups.
An episode of trauma to the limb was the most com-
mon cause of RSD (71% of patients). The mechanisms of
trauma varied and included the following episodes (in
descending order of frequency): motor vehicle accident,
fracture, joint sprain, crush injury, electrical injury, and
stab wound. Other causes for RSD were prior surgical pro-
cedures (carpal tunnel release, n = 4; hand surgery, n = 1;
ankle surgery, n = 4; varicose vein stripping, n = 1), intra-
venous drug infiltration in the hand/forearm in three
patients, and lower limb superficial thrombophlebitis in
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Typical pain clinic treatment protocol for reflex sympathetic dystrophy or complex regional pain syndrome designed to rehabilitate
patient in shortest possible time and initiate safest and most cost-effective therapies first.
one patient. Five patients had spreading RSD develop and
were seen with multiple extremity involvement. Two
patients sustained another episode of trauma during the
follow-up period, had disabling SMP-RSD develop in a
lower extremity, and underwent lumbar sympathectomy.
All the patients had undergone a recent (<3 months)
series of three to six sympathetic chain blocks with 0.25%
bupivacaine hydrochloride that confirmed SMP syn-
drome. For a patient to be considered a candidate for sym-
pathectomy, a reproducible SMP response to the ganglion
block therapy was necessary. The criterion for a positive
response was a greater than 50% reduction in the patient’s
basal pain severity score, on the basis of a visual-analogue
scale from 0 (no pain) to 10 (the worst pain imaginable).
The reduction in pain severity had to persist for at least 2
days and be accompanied by improved muscle strength or
limb mobility. Also, a positive response to sympathetic
block therapy had to occur with most of the blocks for the
patient to be considered a surgical candidate. The number
of sympathetic blocks before sympathectomy ranged from
six to more than 40. Several patients had undergone
monthly sympathetic block therapy for more than 1 year
before surgical sympathectomy. Nine patients had under-
gone prior invasive procedures for pain reduction that
included the following procedures: chemical lumbar sym-
pathectomy (n = 7) or radiofrequency ablation of the stel-
late ganglion (n = 2). During this time interval, the
referring pain clinic specialists estimated that less than one
third of the patients undergoing treatment for RSD were
referred to the vascular center for consideration of surgical
sympathectomy.
Techniques of surgical sympathectomy. All the pro-
cedures were performed with general anesthesia with the
patients admitted the day of surgery. The thoracoscopic
JOURNAL OF VASCULAR SURGERY
Volume 35, Number 2 Bandyk et al 271
technique outline by Ahn et al9 was used to excise the dor-
sal sympathectomy chain from below the stellate ganglion
to the third or fourth thoracic ganglion. The patients were
positioned in the lateral decubitus position, with the arm
elevated and the table flexed to widen the intercostals
spaces for port insertion. A camera port for a 0
degree–angle thoracoscope was introduced in the sixth
intercostal space at the midaxillary line followed by the
introduction of the two to three remaining ports in direct
vision. Adhesions of the lung to the pleural apex were
incised, when necessary, and the sympathetic chain was
visualized at the costovertebral junction. Carbon dioxide
insufflation (low flow, 8-cm H2O pressure) was used to
aid in lung deflation and retraction. Pleural overlying the
sympathetic chain was grasped and incised with electro-
cautery set at the lowest possible level for hemostasis and
tissue cutting. With a hook dissector, the sympathetic
chain was elevated and dissected with scissors and electro-
cautery and the rami of the ganglion was cut. Dissection
began below the stellate ganglion with the placement of a
clip across the inferior aspect of the ganglion, and excision
of the sympathetic proceeded caudal to the third or fourth
thoracic ganglion. An intercostal nerve block with 0.25%
bupivacaine hydrochloride was performed and followed by
the insertion of a 28F chest tube with direct vision. The
incisions were closed with absorbable suture. A chest x-ray
was obtained in the postoperative recovery unit for the
verification of lung expansion. The average procedure
time was approximately 50 minutes.
Lumbar sympathectomy was performed via a trans-
verse incision positioned lateral to the rectus muscle
sheath and midway between the costal margin and iliac
crest. After the injection of the incision site with 0.25%
bupivacaine hydrochloride, skin and external oblique mus-
Table I. Gender, age, duration of reflex sympathetic dystrophy symptoms, and clinical stage of 73 patients who under-
went thoracoscopic cervicodorsal or open lumbar sympathectomy
Type of sympathectomy
Cervicodorsal (n = 46) Lumbar (n = 37) Total (n = 83)
No. of patients 41 32 73
Female patients 30 26 56 (77%)
Male patients 11 06 17 (23%)
Age (years) 35 ± 10.2 36 ± 9.7
Age range (years) (13-66) (14-65)
Patients with bilateral RSD 7 (17%) 8 (25%) 15 (20%)
Cause
Trauma 33 26 5 (71%)
Prior surgical procedure 7 8 15 (18%)
IV infiltration 3 0 3 (4%)
Superficial phlebitis 0 1 1 (1%)
Spreading RSD 3 2 5 (6%)
Duration of RSD symptoms (months) 25 ± 20 26 ± 15
RSD stage at time of sympathectomy*
Stage I 1 1 2 (2%)
Stage II 33 21 54 (65%)
Stage III 11 16 27 (33%)
*See Appendix.
RSD, Reflex sympathetic dystrophy; IV, intravenous.
cle and fascia were incised. A muscle splitting incision of
the internal and transverse abdominal muscles was per-
formed to enter the retroperitoneum. Peritoneum was
retracted medially, and the psoas muscle and genital-
femoral nerve were visualized. The sympathetic chain then
was palpated on the vertebral column, followed by the dis-
section of the chain and ganglion with direct vision.
Ganglions and sympathetic chain from the diaphragm hia-
tus (first lumbar ganglion) to the pelvic brim (fourth lum-
bar ganglion) were excised. After inspection for
hemostasis, the abdominal incision was closed with
absorbable suture. The average procedure time was
approximately 45 minutes.
Patient care after sympathectomy. For the first 24 to
48 hours after sympathectomy, surgical incision pain and
RSD pain were controlled with a patient-activated intra-
venous morphine infusion pump with a basal infusion rate.
The patients were typically discharged on the 2nd or 3rd
postoperative day after thoracoscopic sympathectomy and
on the 3rd to 4th postoperative day after open lumbar
sympathectomy. Discharge pain medications were similar
to the admission regime and were supplemented with oral
doses of hydrocodone (5 to 7.5 mg) and acetaminophen
(325 to 500 mg) every 4 to 6 hours as necessary. The
patients underwent evaluation at 1 week, 4 weeks, and 3
months in the vascular surgery clinic and, subsequently, in
the referring pain clinic. After thoracoscopic dorsal sym-
pathectomy, persistent chest wall, “new” posterior
scapula/shoulder pain was treated in the pain clinic with
trigger point injection of local anesthetics, repeat stellate
ganglion block therapy, or transcutaneous electrical nerve
stimulation (TENS).
Analysis of patient outcomes. Pain reduction, limb
disability, and patient satisfaction after the sympathectomy
procedure were assessed in two ways: review of outpatient
surgery and pain clinic records and administration of a
questionnaire by an independent observer not involved in
the patient’s care or prior procedure. The outcomes ana-
lyzed were chosen for consistency with the literature on
RSD pain reduction with other management options
(chemical sympathectomy, spinal cord stimulation, mor-
phine pump). During the clinical follow-up period, the
following outcomes were analyzed: pain severity score
reduction after sympathectomy at 3-month and 12-month
intervals; frequency of more than 50% pain reduction at
last follow-up examination; disability status at last follow-
up examination, combined with patient satisfaction with
treatment (ie, “Considering the hospitalization, discom-
fort, and expense of surgical sympathectomy, would you
undergo the procedure again for the same result?”); and
additional procedures for pain control. The following
patient and treatment characteristics were considered
independent variables in the statistical analysis: clinical
stage of RSD (I/II versus III), RSD cause, duration of
RSD before intervention (<18 months versus >18
months), patient age (≤35 years versus >35 years), and
type of procedure (thoracoscopic versus open lumbar sym-
pathectomy). The incidence rates of “new” CRPS syn-
dromes and sequelae of sympathectomy were also tabu-
lated relative to the type of sympathectomy procedure or
multiple procedures. Seven patients (10%) were lost to fol-
low-up examination after 1 year. The patient follow-up
period ranged from 8 to 86 months (mean, 30 months).
Statistical analysis. Student t test (paired and
unpaired) was used for the comparison of continuous vari-
able data (duration of RSD, pain severity score) for proce-
dure outcome categories. χ2 test was used for the
comparison of categoric data (patient satisfaction). The
continuous data (age, time, pain severity score) were
recorded as mean ± standard deviation.
RESULTS
No operative mortality or serious morbidity (Horner’s
syndrome, bleeding that needed transfusion, chylothorax,
wound infection) occurred after surgical sympathectomy.
One patient had chest tube bleeding develop after thora-
coscopic dorsal sympathectomy and was returned to the
operative room for electrocautery of bleeding from the
excised thoracic sympathetic chain site. After sympathec-
tomy, all the patients showed clinical signs of regional
sympathetic denervation with a warm dry extremity and
reported significant reduction in RSD pain. In both upper
and lower extremities, hand/finger or ankle mobility was
improved. The length of stay after dorsal sympathectomy
ranged from 2 to 7 days (mean, 3.1 days), with patients
who underwent open lumbar sympathectomy staying, on
the average, 1 day longer. Four patients needed readmis-
sion 1 to 2 days after discharge for control of chest
wall/incisional pain after thoracoscopic dorsal sympathec-
tomy.
Postprocedural sympathalgia (ie, postsympathectomy
neuralgia) developed in a significant number of patients
after both thoracoscopic dorsal (11 of 46 procedures;
24%) and lumbar (seven of 37 procedures; 19%) sympa-
thectomy. The patients typically had a “new,” constant
deep pain 1 to 2 weeks after operation either in the poste-
rior upper back over the scapula after dorsal sympathec-
tomy or in the anterolateral thigh after lumbar
sympathectomy. These postsympathectomy pain syn-
dromes were effectively treated with narcotics, with anti-
inflammatory drugs, and, in the patients for dorsal
sympathectomy, with trigger point/proximal ganglion
block therapy or TENS. All but one patient reported res-
olution of pain/discomfort by 2 to 3 months. Although
most women indicated breast pain or paresthesias for 4 to
6 weeks after thoracoscopic dorsal sympathectomy, in only
one woman was the breast sensitivity persistent and both-
ersome.
Patient rating scores of presympathectomy RSD pain
severity were similar in patients who underwent dorsal
(8.5 ± 1.2) or lumbar (8.4 ± 1.6) sympathectomy. After
discharge, essentially all the patients indicated RSD pain
reduction and more comfortable warm feelings in the
sympathectomized limbs. By 2 to 3 months after sympa-
thectomy, seven patients (10%; cervicodorsal, n = 5; lum-
bar, n = 2) had conditions that were judged treatment
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failures with no reduction in pain severity or limb disabil-
ity. The absence of RSD pain reduction was apparent by 1
month in most of these patients, but because of residual
incision pain or the development of postsympathectomy
neuralgia, assessment of benefit from sympathectomy was
not possible. All the remaining patients testified to more
than 50% pain reduction at 3 months and improved limb
mobility. Comparative reduction of pain severity scores (P
> .1) was achieved after either cervicodorsal or lumbar
sympathectomy, with individual patient scores ranging
from 0 to 9 (Table II). The mean pain severity scores at 3
months after dorsal (3.3 ± 1.5) and lumbar (3.1 ± 1.5)
sympathectomy were similar (P > .05) and comparable
with the patient rating of pain reduction after sympathetic
block (3.5 ± 1.6 and 3.1 ± 1.5, respectively).
The pain severity scores increased in both patient
treatment groups by 1 year after sympathectomy. An addi-
tional eight patients after dorsal sympathectomy and four
patients after lumbar sympathectomy indicated increased
RSD pain and limb disability beyond 3 months. Overall, at
1 year after sympathectomy or at last follow-up examina-
tion, a pain severity score of more than 5 and persistent
RSD limb disability indicated no benefit after 13 of 46
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thoracoscopic dorsal (28%) and six of 37 lumbar (16%)
sympathectomy procedures. The pain severity scores
increased significantly in both the dorsal sympathectomy
patient group (P < .001; from 3.3 at 3 months to 4.0 at
last follow-up examination) and the lumbar sympathec-
tomy patient group (P = .048; from 3.1 ± 1 at 3 months
to 3.6 ± 1 at last follow-up examination).
Long-term patient satisfaction (lower pain severity
score, increased limb mobility, patient would undergo
procedure again) was not influenced by the RSD stage,
duration of RSD before surgical sympathectomy, or
patient age (Tables II and III). The patient-provided pain
severity scores at 3 months and 1 year were similar (P >
.05) in each sympathectomy group, regardless of RSD
duration or patient age. The overall patient satisfaction
with the procedure was 71% (33 of 46 procedures) after
thoracoscopic dorsal sympathectomy and 84% (31 of 37
procedures) after open lumbar sympathectomy. A pain
severity score of less than 3, which indicated minimal pain
and limb disability, was recorded by the patient after 11 of
46 dorsal sympathectomy procedures (24%) and after nine
of 37 lumbar sympathectomy procedures (24%). An addi-
tional 50% of the patients indicated benefit from sympa-
Table II. Pain severity scores* (mean ± standard deviation) of 73 patients with sympathetically maintained reflex sym-
pathetic dystrophy who underwent treatment with thoracoscopic cervicodorsal (n = 46) or open lumbar sympathec-
tomy (n = 37)
Pain severity score provided by patient
After sympathectomy
Type of sympathectomy Basal RSD pain After stellate ganglion block At 3 months At 1 year
Cervicodorsal 8.5 ± 1.2 3.5 ± 1.4 3.2 ± 1.5 4.3 ± 2.5†
Lumbar 8.4 ± 1.6 3.5 ± 1.6 3.1 ± 1.0 3.6 ± 1.1†
After sympathectomy
Outcomes relative to patient variable At 3 months At 1 year
Time from injury to sympathectomy (<18 months)
Lumbar (n = 15) 3.0 ± 1 3.3 ± 1.7
Cervicodorsal (n = 26) 3.4 ± 1.3 3.9 ± 2†
Time from injury to sympathectomy (>18 months)
Lumbar (n = 22) 3.1 ± 1 3.7 ± 2.1
Cervicodorsal (n = 20) 3.2 ± 1.9 4.7 ± 3†
Patient age ≤ 35 years
Lumbar (n = 21) 3.2 ± 1.1 4.0 ± 2.1†
Cervicodorsal (n = 22) 3.1 ± 1.7 3.9 ± 2.5†
Patient age > 35 years
Lumbar (n = 16) 2.9 ± 0.7 3.0 ± 1.2
Cervicodorsal (n = 24) 3.5 ± 1.4 4.7 ± 2.4†
Stage I/II of RSD syndrome
Lumbar (n = 21) 3.1 ± 1.1 3.4 ± 1.9
Cervicodorsal (n = 34) 3.1 ± 1.4 3.7 ± 2.1
Stage III of RSD syndrome
Lumbar (n = 16) 3.0 ± 1.0 3.7 ± 2†
Cervicodorsal (n = 11) 3.9 ± 1.5 5.5 ± 2.8‡
*Intensity of pain scale (no pain, 0; worst pain imaginable, 10).
†P < .05 compared with 3-month pain severity score.
‡P = .014 compared with reflex sympathetic dystrophy stage I/II.
RSD, Reflex sympathetic dystrophy.
thectomy, but the degree of initial RSD pain reduction
lessened with time. Despite an increase in pain, these
patients reported that their ability to participate in physi-
cal/occupational therapy and subsequently perform
daily/work activities with the limb was improved. The
mean pain score of the patients who were satisfied with the
procedure was 3 ± 2 after dorsal and 3 ± 1.1 after lumbar
sympathectomy. Six of nine patients (67%) with prior
chemical/radiofrequency ganglion ablation and persistent
RSD indicated benefit from dorsal (n = 2) or lumbar (n =
4) sympathectomy.
The 19 patients with conditions that were early sym-
pathectomy failures or who later had increasing RSD pain
scores develop (dorsal, 7.3 ± 1.1; lumbar, 6.5 ± 2.4)
underwent treatment with several methods, including
spinal cord stimulation (n = 10), morphine pump (n = 7),
additional surgical procedures (thoracic outlet decompres-
sion, n = 2; orthopedic procedures, n = 2; ulnar nerve
release procedure, n = 1), and continued pain clinic treat-
ments (TENS, clonidine hydrochloride patches, sympa-
thetic blocks, biofeedback, drug therapy).
During the mean follow-up period of 30 months, five
patients (7%) had a “new” CRPS develop (spreading RSD,
n = 3; new episode of trauma leading to RSD, n = 2). No
patient underwent amputation for RSD syndrome.
Compensatory sweating syndromes that affected the face,
back, or other limbs were indicated by three patients after
lumbar sympathectomy and by five patients after dorsal
sympathectomy (overall incidence rate, 8 of 83 proce-
dures; 10%). All conditions were judged by the patients to
be nondisabling. One patient after bilateral dorsal sympa-
thectomy and a prior unilateral chemical lumbar sympa-
thectomy had orthostatic hypotension develop that
improved with mineral corticoid administration. One
patient with RSD of all limbs who underwent bilateral
dorsal and lumbar sympathectomy during a period of 2
years testified to satisfaction from all the procedures and
no disabling neurologic, compensatory sweating, or heat
intolerance sequelae. Seven of nine patients (78%) who
underwent multiple sympathectomy procedures for RSD
or spreading RSD indicated benefit from all the proce-
dures. All the patients had benefitted from the initial sym-
pathectomy procedure.
DISCUSSION
The management of RSD syndromes is relevant to vas-
cular surgeons because many patients are initially referred
for evaluation of extremity pain, cyanosis, skin temperature
changes, and edema—all of which can imitate arterial/
venous disease. The vascular examination results are
invariably normal in these young, healthy, and commonly
female patients, but the limb pain is deemed excruciating
and disabling. When compared with the pain associated
with cancer, arthritis, or childbirth, RSD pain is com-
monly rated as one of the most intense imaginable.
Although there is a long history of surgical sympathec-
tomy for pain management, evidence-based data that sup-
port its application for the disability caused by RSD come
primarily from noncontrolled trial results, retrospectively
reviewed and analyzed or reported by treating physicians.
Most surgical series involve a retrospective analyzed series
of patients that indicates the early effectiveness of the pro-
cedure with pain reduction in 60% to 90% of patients.4-9
Adverse effects of sympathectomy, durability of the proce-
dure in terms of pain reduction, or late functional status of
patients have not been systematically reported, and thus
failures may have been underestimated. These results have
led some pain specialists to question the benefit of the sur-
gical sympathectomy.11
Our review showed that most patients with a docu-
mented sympathetically maintained RSD syndrome did
benefit from surgical sympathectomy. Pain reduction and
improved function of the involved limb was documented
by the treating physicians, by the log of patient-rated
severity scores, and by an independent observer not
involved in the patient’s care who interviewed patients
beyond 1 year of the procedure. Only one quarter of the
patients indicated no or minimal residual disability or pain
(ie, were “cured” with surgical sympathectomy). Most
patients testified to sustained, long-term benefit when
queried as to whether they would undergo the sympa-
thectomy procedure again. Of note, the outcomes after
the more minimally invasive thoracoscopic dorsal sympa-
thectomy were comparable with the outcomes of lumbar
sympathectomy performed via a standard open surgical
exposure. Patient age, duration of RSD syndrome, and
RSD disease stage also did not significantly influence out-
comes. Overall, the patient satisfaction and the pain reduc-
tion (cervicodorsal, 72%; lumbar, 84%) was comparable
with the patient series reported by Olcott et al6 (91% of
patients [n = 35] benefitted after open cervicodorsal or
lumbar sympathectomy, including use of extended sympa-
thectomy for nonresponders), by AbuRharma et al7 (71%
satisfactory outcome after open surgical excision; 28
patients), and by Johnson et al12 (60% pain relief after tho-
racoscopic sympathectomy; 10 patients).
The incidence rate of postsympathectomy problems
was similar after the two types (cervicodorsal and lumbar)
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Table III. Patient satisfaction with sympathectomy rela-
tive to type of procedure and reflex sympathetic dystro-
phy stage
Patient would 
undergo 
No. of procedures procedure again
Type of sympathectomy
Thoracoscopic dorsal 46 33* (72%)
Open lumbar 37 31† (84%)
Total 83 64 (77%)
Stage of RSD syndrome
Stage I or II 56 44 (78%)
Stage III 27 20 (74%)
*Pain severity score, 3 ± 2.
†Pain severity score, 3 ± 1.1.
RSD, Reflex sympathetic dystrophy.
of surgical sympathectomy. Postsympathectomy neuralgia
or sympathalgia developed within 1 to 2 weeks in approx-
imately 20% of the patients. The pain was characterized as
a spontaneously occurring deep aching pain in the poste-
rior shoulder (after cervicodorsal sympathectomy) or
anterolateral thigh (after lumbar sympathectomy).
Patients often conclude that this is a “new” RSD syn-
drome and need to be assured that it is not. The pain can
be effectively treated with methods such as trigger point
and proximal sympathetic ganglion block therapy or
TENS and with narcotics or nonsteriodal antiinflamma-
tory medications. The symptoms typically abated by 3
months after the procedure. Thus, the patients should be
informed that sympathectomy may be a two-step proce-
dure: destruction of the sympathetic nerves followed by
one or more additional sympathetic/trigger point blocks.
The mechanism of postsympathectomy pain is hypothe-
sized to be the result of a complex neuropathic and cen-
tral deafferentation/reafferentation syndrome caused by
transection or paraspinal somatic and visceral afferent
axons within the sympathetic chain, subsequent cell death
of axotomized afferent neurons, and persistent sensitiza-
tion of spinal nociceptive neurons by pain conditions pres-
ent before sympathectomy.13 Other adverse sequelae of
sympathectomy, such as disabling compensatory sweating
and chronic neurologic pain, were uncommon in this
series. Most patients noted improvements in daily activi-
ties such as sleeping, walking, dressing, driving, and sexual
activity. However, two thirds of the patients with RSD as
a result of work-related trauma have received permanent
disability since their injury, and disabilities related to joint
contracture or severe muscle atrophy did not improve.
Not all the patients benefitted from surgical sympa-
thectomy. Despite compelling evidence that SMP syn-
drome was present on the basis of more than 50% pain
reduction after multiple sympathetic blocks, 28% of
patients after dorsal sympathectomy and 16% of patients
after lumbar sympathectomy indicated no prolonged ben-
efit and regretted that they had agreed to undergo the
procedure. The incidence rates of sympathectomy failure
was similar in patients with stage II (22%) and stage III
(26%) RSD syndromes. Pain specialists consider long-term
more than 50% reduction in pain severity for greater than
one half of patients with RSD as a “good” therapeutic
result, and thus, in this respect, surgical sympathectomy
can be considered efficacious. Reports of spinal cord stim-
ulation for chronic, intractable pain have shown continued
pain relief in approximately 50% of patients.14,15 It is a dis-
service to patients with RSD and to the medical profession
to promise 90% or greater success rates of pain reduction
with invasive procedures. Importantly, there is no test that
will accurately identify the “best” candidate for surgical
sympathectomy. Patient selection requires documentation
of SMP response with sympathetic block, a well-informed
and motivated patient, and availability of family and finan-
cial support for postsympathectomy rehabilitation and
physical therapy. Many patients have concomitant myofas-
cial pain syndromes and will not experience prolonged
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improvement of symptoms, despite initial amelioration in
pain after sympathectomy. Patients in this study whose
conditions did not benefit from sympathectomy were rec-
ommended to try other methods, including use of a mor-
phine pump and spinal cord stimulation for pain
reduction. No patient in this study underwent limb ampu-
tation after sympathectomy for persistent RSD syndrome.
The activation of the sympathetic system after injury is
important for survival. The autonomic system response
causes blood vessels in the skin to contract, forcing blood
into muscle and enhancing “fight or flight” ability.
Ordinarily, the sympathetic system shuts down within
minutes to hours after injury, but in the individuals in
whom RSD develops, sympathetic activity remains hyper-
active. The mechanism by which injury triggers RSD/
CRPS is unclear. Theoretically, the abnormal sympathetic
activity at the site of injury may cause an inflammatory
response that causes blood vessels to spasm, leading to
more swelling and pain. When RSD syndrome is recog-
nized and treated early with patient education, antiinflam-
matory drugs, sympathectomy blocks, and physical
therapy, a permanent cure can be achieved. Untreated, the
syndrome can lead to intractable pain and swelling that
extends beyond the area of original trauma. Spreading
RSD syndrome with diffuse limb pain, muscle wasting,
and joint immobility (ie, stage III disease) is more difficult
to treat. The goal should be treatment but not overtreat-
ment. Documentation of a sympathetically maintained or
independent RSD syndrome provides useful information
for treatment options, especially with the identification of
those patients who may benefit from sympathectomy or
other pain reduction interventions.15,16 At present, repro-
ducible more than 50% pain reduction and improved limb
mobility after sympathetic ganglion block remains the best
method for predicting the response to surgical sympathec-
tomy. A failed chemical or radiofrequency sympathectomy
should not exclude the patient if SMP-RSD syndrome can
be verified.
Neurologic pain and compensatory sweating syn-
dromes were common after both thoracoscopic dorsal and
open lumbar sympathectomy, but most conditions
resolved within weeks or were nondisabling. In only two
patients was the development of a persistent postsympa-
thectomy sympathalgia the reason for patient dissatisfac-
tion with the procedure. Use of the less invasive
thoracoscopic technique for dorsal sympathetic chain exci-
sion did not decrease the incidence rate of postoperative
sympathalgia reported in the literature. The endoscopic
technique was well received by the patients and was asso-
ciated with a shorter hospital stay than was open lumbar
sympathectomy procedure. Proper informed consent for
surgical sympathectomy should detail the possibility of
“no benefit” and the potential for transient neuropathic
pain syndromes. Physician and patient review of the 
clinical practice guidelines developed by the Reflex
Sympathetic Dystrophy Syndrome Association of America
(www.rsds.org) can assist patients in making informed
choices about their treatment. The development of a
“new” CRPS did occur in 7% of the patients, which
emphasizes the importance of patient education regarding
susceptibility to RSD after trauma and the possibility of
spreading RSD. It is essential that patients avoid reinjury
during their postoperative physical therapy sessions. Given
the incomplete relief of RSD in most patients and the
potential for adverse sequelae, only patients with a docu-
mented sympathetically maintained RSD syndrome should
be considered for surgical sympathectomy. Pain reduction
and instruction for the patients with RSD on use of the
affected limb through activities of daily living can be
improved with sympathectomy.
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Appendix. Staging of reflex sympathetic dystrophy/
complex regional pain syndrome*
Stage I
Onset of severe pain limited to site of injury
Increased sensitivity of skin to touch and light pressure (hyper-
esthesia)
Localized swelling
Muscle cramps
Stiffness and limited mobility
Skin color/temperature changes from erythema/warm to 
cyanosis/cold
Increased sweating (hyperhidrosis)
Stage II
Diffuse severe pain not limited to site of injury
Spreading swelling that may change from soft to brawny
Changes in hair (coarse, scant) and nails (growth changes, 
brittle, grooved)
Early changes of osteoporosis
Muscle atrophy
Stage III
Marked atrophy of muscle and skin
Intractable pain with involvement of entire limb and adjacent 
trunk
Bilateral or multiple limb involvement
*Adapted from Clinical Practice Guidelines of Reflex Sympathetic
Dystrophy Syndrome Association of America (www.rsds.org).
DISCUSSION
Dr Ali F. AbuRahma (Charleston, WVa). This is the only large
series, actually, that I see in the last 8 years that presents a decent
experience about causalgia since we presented our data to this
group over 9 years ago. One thing I would like to reemphasize
for the group of people here is that the timing between initial
injury and the initial treatment, whether a chemical or surgical
sympathectomy, is absolutely critical, if you really want to make
sure that you do not get negative results. And as part of that, I
have quite a few questions for you.
Have you encountered anything of this entity after lumbar
laminectomies? I noticed you indicated type of injury, but I have
not seen any in your slide or even in the manuscript about the
causalgia after lumbar laminectomy, and we have seen a few of
these.
I noticed also in your manuscript that you resected L1
through L4. And generally we like to get L2 and L3, unless the
pain is really impressive, extensive, from the upper thigh all the
way down to the foot. Otherwise, we do not go that extensive.
Have you considered contralateral lumbar sympathectomies for
people who failed? I am sure you are aware of the fact of the con-
tralateral cross fibers and fibers from one side to the other. For the
people who failed, would you have thought of contralateral lum-
bar sympathectomy?
Have you had any experience with the laparoscopic retroperi-
toneal lumbar sympathectomy of which we had few?
And finally, I did like what I saw in terms of your referring to
the complex regional pain syndrome. I see it is somewhere in the
manuscript, but I would like really to emphasize maybe a little
more comment on it, because we are dealing with multiple col-
leagues and many of them deny these terms and they like to use
complex regional pain syndrome.
Dr Dennis F. Bandyk. We have observed postsympathectomy
neuralgia after lumbar sympathectomy in 19% of patients. As 
I indicated, it was self-limiting and manifested as primarily thigh
pain.
We tried to excise as much of the lumbar sympathetic chain
as possible and have not performed any contralateral sympathec-
tomies in this patient group.
We have not, in this series, performed any laparoscopic sympa-
thectomies to date, but I think this procedure would be less inva-
sive and it is something we would certainly look into in the future.
In respect to the term “complex regional pain syndrome:” it
refers to a larger group of pain patients, some of whom may have
sympathetic independent pain. Most pain clinic specialists, such as
the RSD Association, when they identify a patient with sympa-
thetically mediated pain, would use the term RSD to describe
those patients.
Dr Josi Fernandez (Lisbon, Portugal). We have a similar expe-
rience, and I have been dealing with this kind of patient for a few
years. One of the difficulties is to correlate pain with hyperactiv-
ity of the sympathetic system. One of the clinical signs that 
I found very useful is the presence of coldness and excessive
sweating, and these signs have shown to be predictors of a good
and durable response to sympathectomy.
Did you have the same experience as well, or do you just rely
on the effect of sympathetic block?
Dr Bandyk. Dr Fernandez’s question is whether or not other
signs of autonomic hyperactivity are commonly present in these
patients. We have observed these signs in the minority of the
patients. If present, such signs of excess sympathetic system activ-
ity would indicate those patients as very good candidates for sym-
pathectomy. In the majority of patients, the criteria of more than
50% pain reduction after a sympathetic block can be used to indi-
cate sympathetic-maintained pain syndrome.
Dr James M. Malone (Scottsdale, Ariz). Very nice paper, one
I think that is really important for vascular surgeons who on the
average do not see many patients with RSD. I came to the micro-
phone to echo one of your points and to ask a question.
You mentioned how minimal the trauma can be that induces
RSD. I am sure in Florida you have as many insects as we have in
Arizona. I have seen three patients in 6 months with insect bites
as the precipitator of RSD, which to me was absolutely amazing.
The question has to do with the timing. Your data were bro-
ken down into rather long time periods traditionally for the treat-
ment of RSD, and so this may be an unfair question. But most
people who talk about success rates focus on 6 months as the
drop-dead period in which to do surgery, and I wonder if you
could make any comments?
Dr Bandyk. The shortest duration of RSD prior to sympa-
thectomy was a patient who had his injury 6 months beforehand.
Most patients had RSD for a longer time, and their disease
process was more advanced. Some of these patients have under-
gone as many as 60 sympathetic blocks. The choice of less or
greater 18-month time intervals for duration of RSD was arbi-
trary but allowed us to have equal numbers of patients in the two
time periods, and statistical analysis indicated differences in out-
come relative to duration of RSD symptoms.
Dr Samuel S. Ahn (Los Angeles, Calif). I had not planned to
rise, but since you quoted me, I wanted to make a few corrections
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on the techniques they described. Over the years, I have refined
the technique, so it is now a little different.
First of all, the port placement is very critical. And I put the
ports as far posterior as I can so that the lung, which falls anterior,
is not in the way. I use the mid chest line for the first port, the
posterior chest line for the second port, and then the anterior
chest line for the third port.
Secondly, I use sharp dissection preferentially. I use electro-
cautery as little as possible, only as necessary. I do not cauterize
anywhere near the nerves. I think that is important to prevent any
postoperative neuralgia. Since adopting this policy 3 years ago, 
I have not seen any postoperative neuralgia.
Thirdly, I now use 7-mm ports for 5-mm instruments and
that has allowed me to discharge these patients home on the same
day as the operation. The chest tube comes out in the recovery
room if there is no air leak, and 95% of patients go home the same
day. I think you had 2 to 4 days in the hospital.
I was a little curious about your RSD patients that had these
worsening migratory symptoms. How do you know that these
patients did not have this systemic RSD to start with and were not
already in the process of developing further symptoms? You
implied that your surgery may have induced it somehow. So the
question to you is, how can you differentiate preexisting from
induced RSD?
The final comment is that I noticed that two thirds to three
quarters of RSD patients have a positive stress test for thoracic
outlet syndrome (TOS). Conversely, some of my TOS patients
present with RSD. If I just take out their first rib and decompress
their TOS, their RSD resolved in most cases. Have you noticed
this in your patient population? Did any of your patients have
underlying TOS that may have accounted for their RSD?
Dr Bandyk. We have observed your changes in the port posi-
tion and size of the camera port. I agree port placement is impor-
tant.
Relative to length of stay, there is a difference in patients who
undergo sympathectomy for RSD versus hyperhidrosis. The
hyperhidrosis patients, they go home earlier, usually the next day.
But the RSD pain patients we have treated usually require mor-
phine pumps after the surgery and are discharged from the hos-
pital in 2 to 3 days.
Fifteen of our patients presented with bilateral symptoms
and had RSD that progressed. Even after one limb was treated
and pain reduction occurred, some of these patients were nonre-
sponders in the contralateral limb. We have found that patients
who are nonresponders frequently do not respond to other treat-
ments. We have performed first rib resections with no improve-
ment. Six of the nonresponding patients had spinal cord
stimulators placed, and only one benefitted. A number of the
patients had been prescribed narcotic pumps at home with short-
term success. RSD nonresponders remain a difficult group of
patients to manage.
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